Companies - March 11, 2015
SARomics Opens US Sales Office
SARomics Biostructures has opened a sales office in Cambridge, Massachusetts, in the U.S. “We are excited about the move to this vibrant area and look forward to get the opportunity to work with world-class companies and their ground breaking projects,” says Björn Walse, CEO of SARomics Biostructures, whose headquarters is in the Medicon Valley region […]
Companies - March 6, 2015
Novo Nordisk on ‘100 Best Companies’ List
For the seventh consecutive year, Novo Nordisk has made the FORTUNE magazine “100 Best Companies to Work For” list, this year ranking 66th. The hundreds of companies that apply each year are evaluated on five criteria: credibility, respect, fairness, pride and camaraderie by the creator of the list, Great Place to Work®. “We strive to […]
Companies - February 27, 2015
AstraZeneca at Life Science Event
Danish biotech companies and scientists from the University of Copenhagen are invited to meet April 9 with BioPeople, the University of Copenhagen, the Capital Region and AstraZeneca Nordic Outreach to learn more about AstraZeneca’s areas of research focus and activities in the Danish and Nordic life science sector. Attendees also will have the chance to interact and […]
Companies - February 18, 2015
AZ Shareholders to Nominate Non-Executive Director
Cornelia Bargmann will be nominated by AstraZeneca shareholders as a non-executive director at the company’s annual general meeting on April 24. The Board of Directors is also proposing the appointment of Bargmann to AstraZeneca’s Science Committee. John Varley, senior independent non-executive director, and Nancy Rothwell, non-executive director, both intend to retire from the Board of […]
Companies - February 9, 2015
Novo Nordisk Files Annual Reports
Novo Nordisk A/S has filed its Annual Report 2014 on Form 20-F for the financial year 2014 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of the Novo Nordisk A/S Annual Report 2014. The reports are available at the SEC’s website, www.sec.gov, as well as on novonordisk.com. Shareholders and ADR holders may receive a hard copy of […]
Companies - January 20, 2015
Cytomed to Make Flu Drug in Finland
Russian-owned company Cytomed, which has a pharmaceutical plant near Lappeenranta in eastern Finland, won approval from the Finnish Medicines Agency to start production of its influenza medicine Cytovir-3. Cytomed’s Finnish pharmaceutical plant was built in 2012 and is focused on producing drugs for the Russian market. Julia Volkov, Cytomed’s CEO in Finland, said exports to […]
